UnitedHealth Group Incorporated (UNH) earnings on April 21, 2026

Before the market opens Q1 2026

More UnitedHealth Group Incorporated earnings

Prior outlook: Optimistic Outcome: Accurate

The stock jumped sharply after the company released its quarterly results. It climbed to a 10% gain during the day before ending up about 7% higher.

UNH price around the earnings

346.16

Change: +7.0%

2026-04-21, 20:00 UTC

Start of the measured window End of the measured window
323.48 334.61 345.75 356.88 323.48
Price series around the eventClosing price per minute from before the event to the end of the measured window.
April 21, 2026
  • Price: green if it ends above the starting price; red if it ends below
  • Start of the measured window
  • End of the measured window
  • Starting price
Price series around the event

Prior thesis

Prior outlook: Optimistic Outcome: Accurate

Thesis published

Stock is strong but near resistance; upside appears limited.

The stock has experienced a significant rally, and while sentiment is positive, it is now market review near a key resistance level. Analysts offer minimal upside potential from current prices, suggesting the stock may be overextended.

Context analyzed before publication

Summary
The stock is strong but near resistance; the scenario appears modestly optimistic.
Reasoning
The stock has experienced a significant rally, and while sentiment is positive, it is now market review near a key resistance level. Analysts point to a minimally optimistic scenario from current prices, suggesting the stock may be overextended.
Playbook
Given the stock's rapid rise and proximity to resistance, the scenario suggests waiting for a pullback or a clearer context of further upside before considering new investments.
Trend
First evaluation, no trend yet

Analysts

Drivers

  • Analysts Neutral

    Most analysts recommend buying the stock, but their price targets suggest only a small potential gain from current levels. This indicates that much of the recent price increase may already reflect future expectations.

Evidence

Analyst consensus
Buy
Consensus average (1-5)
1.75
Analysts covering the stock
26
Average price target
361.73
Lowest price target
278
Highest price target
440
Upside to price target
2.6%
Quarterly earnings growth
-99.8%
Revenue growth
12.3%
Forward EPS
20.12
Trailing EPS
13.23
Analyst moves in the last 60 days
3
  • Strong buy: 7
  • Buy: 15
  • Hold: 5
  • Sell: 1
  • Strong sell: 0
Strong buy
7
Buy
15
Hold
5
Sell
1
Strong sell
0
  • April 20, 2026 · Jefferies: Maintains rating (Buy → Buy)
  • April 7, 2026 · Bernstein: Maintains rating (Outperform → Outperform)
  • April 1, 2026 · Raymond James: Upgrades rating (Market Perform → Outperform)

News and sentiment

Drivers

  • News & sentiment Positive

    Online retail investor sentiment is overwhelmingly positive and aligned with the stock's price movement. While this indicates strong retail interest, it also suggests a potentially crowded case, which could increase risk.

Evidence

Sentiment
Sentiment
Constructive
Mention volume
Low
Normalized volume
33%
News
Sources (7)
  • Valmont Industries Posts Upbeat Q1 Results, Joins UnitedHealth Group, Quest Diagnostics And Other Big Stocks Moving Higher On Tuesday — Benzinga
  • Stock Market Today: Dow Jones, S&P 500 Futures Edge Higher With Eyes On Iran Talks—Apple, UnitedHealth, 3M In Focus (UPDATED) — Benzinga
  • UnitedHealth Raises Profit Outlook As Medical Costs Ease — Benzinga
  • UnitedHealth Group FY2026 GAAP EPS expected to be more than $17.35 vs $16.84 Est — Benzinga
  • UnitedHealth Group FY2026 Adj EPS expected to be more than $18.25 vs $17.86 Est — Benzinga
  • UnitedHealth Group Q1 Adj. EPS $7.23 Beats $6.58 Estimate, Sales $111.721B Beat $109.579B Estimate — Benzinga
  • UnitedHealth, General Electric And 3 Stocks To Watch Heading Into Tuesday — Benzinga

Technicals

Drivers

  • Technical Negative

    The stock has surged recently, significantly outperforming the market. However, it is now very close to a major resistance level, with substantial downside risk if it fails to break through, while the scenario appears limited.

Evidence

Average true range (ATR)
3.2%
Distance to 52-week high
-19.7%
14-day change (14d)
+28.6%
30-day change
+24.7%
30-day relative strength
+20.4%
Benchmark change
+4.3%
Nearest support
256
Nearest resistance
357.65
Volume accumulation ratio
0.93

Trends

Evidence

Average earnings surprise
+1.4%
  • April 21, 2026: actual EPS 7.23 vs estimate 6.6 (surprise +9.5%)
  • January 27, 2026: actual EPS 2.11 vs estimate 2.11 (surprise +0.2%)
  • October 28, 2025: actual EPS 2.92 vs estimate 2.81 (surprise +4.0%)
  • July 29, 2025: actual EPS 4.08 vs estimate 4.45 (surprise -8.2%)

Expected move

There is no implied-move data available for this event.

Reactions over its last 18 earnings

Median move
4.7%
75th percentile move
7.1%
90th percentile move
11.9%
Up / down moves
9 / 9
Average up move
+3.6%
Average down move
-8.0%

Monitoring and close

What UnitedHealth Group Incorporated reported

There is no monitoring data available for this event.

Pre-market second reading after the results

There is no second reading available for this event.

How the stock reacted

Outcome
Accurate
Consolidated
+7.0%
Max favorable move (MFE)
10.6%
Max adverse move (MAE)
0%